{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:08:30Z","timestamp":1790312910023,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T00:00:00Z","timestamp":1277856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients on high-dose bisphosphonate and immunosuppressive therapy have an increased risk of bisphosphonate-related osteonecrosis of the jaw (BRONJ); despite the disease severity, its pathophysiology remains unknown, and appropriate therapy is not established. Here we have developed a mouse model of BRONJ-like disease that recapitulates major clinical and radiographic manifestations of the human disease, including characteristic features of an open alveolar socket, exposed necrotic bone or sequestra, increased inflammatory infiltrates, osseous sclerosis, and radiopaque alveolar bone. We show that administration of zoledronate, a potent aminobisphosphonate, and dexamethasone, an immunosuppressant drug, causes BRONJ-like disease in mice in part by suppressing the adaptive regulatory T cells, Tregs, and activating the inflammatory T-helper-producing interleukin 17 cells, Th17. Most interestingly, we demonstrate that systemic infusion with mesenchymal stem cells (MSCs) prevents and cures BRONJ-like disease possibly via induction of peripheral tolerance, shown as an inhibition of Th17 and increase in Treg cells. The suppressed Tregs\/Th17 ratio in zoledronate- and dexamethasone-treated mice is restored in mice undergoing salvage therapy with Tregs. These findings provide evidence of an immunity-based mechanism of BRONJ-like disease and support the rationale for in vivo immunomodulatory therapy using Tregs or MSCs to treat BRONJ. \u00a9 2010 American Society for Bone and Mineral Research<\/jats:p>","DOI":"10.1002\/jbmr.37","type":"journal-article","created":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T13:37:58Z","timestamp":1264772278000},"page":"1668-1679","source":"Crossref","is-referenced-by-count":193,"title":["Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw\u2013like disease in mice"],"prefix":"10.1093","volume":"25","author":[{"given":"Takashi","family":"Kikuiri","sequence":"first","affiliation":[{"name":"Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takyoshi","family":"Yamaza","sequence":"additional","affiliation":[{"name":"Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunzhou","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsheng","family":"Li","sequence":"additional","affiliation":[{"name":"Salivary Gland Disease Center and the Molecular Laboratory for Gene Therapy and Tooth Regeneration, Capital Medical University School of Stomatology, Beijing, people's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chider","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WanJun","family":"Chen","sequence":"additional","affiliation":[{"name":"National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Wang","sequence":"additional","affiliation":[{"name":"Salivary Gland Disease Center and the Molecular Laboratory for Gene Therapy and Tooth Regeneration, Capital Medical University School of Stomatology, Beijing, people's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh D","family":"Le","sequence":"additional","affiliation":[{"name":"Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Shi","sequence":"additional","affiliation":[{"name":"Center for Craniofacial Molecular Biology, University of Southern California School of Dentistry, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,6,30]]},"reference":[{"key":"2024020320130219100_bib1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/14712598.5.6.817","article-title":"New therapeutic agents for the treatment of bone diseases","volume":"5","author":"Lipton","year":"2006","journal-title":"Expert Opin Biol Ther."},{"key":"2024020320130219100_bib2","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol."},{"key":"2024020320130219100_bib3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long-term follow-up of two randomized, placebo-controlled trials","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer."},{"key":"2024020320130219100_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0","article-title":"Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases","volume":"91","author":"Berenson","year":"2001","journal-title":"Cancer."},{"key":"2024020320130219100_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020320130219100_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","author":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"2024020320130219100_bib7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/154405910708601101","article-title":"Osteonecrosis of the jaws and bisphosphonate therapy","volume":"86","author":"Ruggiero","year":"2007","journal-title":"J Dent Res"},{"key":"2024020320130219100_bib8","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.amjmed.2008.12.005","article-title":"Osteonecrosis of the jaw and the role of bisphosphonates: a critical review","volume":"122","author":"Silverman","year":"2009","journal-title":"Am J Med"},{"key":"2024020320130219100_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.oraloncology.2009.01.002","article-title":"Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update","volume":"45","author":"Bagan","year":"2009","journal-title":"Oral Oncol"},{"key":"2024020320130219100_bib10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2024020320130219100_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00774-009-0047-9","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid","volume":"27","author":"Cetiner","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"2024020320130219100_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/14740338.7.4.491","article-title":"Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management","volume":"7","author":"Wimalawansa","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"2024020320130219100_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density","volume":"346","author":"Reid","year":"2002","journal-title":"N Engl J Med"},{"key":"2024020320130219100_bib14","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"2024020320130219100_bib15","doi-asserted-by":"crossref","first-page":"18.1","DOI":"10.1146\/annurev.med.60.063007.134350","article-title":"Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management","volume":"60","author":"Ruggiero","year":"2009","journal-title":"Annu Rev Med"},{"key":"2024020320130219100_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.327.7413.469","article-title":"Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer","volume":"327","author":"Ross","year":"2003","journal-title":"BMJ"},{"key":"2024020320130219100_bib17","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"2024020320130219100_bib18","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1001\/jama.295.24.2833","article-title":"Reports of adverse events from bone drugs prompt caution","volume":"295","author":"Kuehn","year":"2006","journal-title":"JAMA"},{"key":"2024020320130219100_bib19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jnci\/djm025","article-title":"Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A Population-Based Analysis","volume":"99","author":"Wilkinson","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2024020320130219100_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"2024020320130219100_bib21","doi-asserted-by":"crossref","first-page":"e2615","DOI":"10.1371\/journal.pone.0002615","article-title":"Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents","volume":"3","author":"Yamaza","year":"2008","journal-title":"PLoS ONE"},{"key":"2024020320130219100_bib22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal Stem Cell Transplantation Reverses Multi-Organ Dysfunction in Systemic Lupus Erythematosus Mice and Humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"2024020320130219100_bib23","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2008-10-182246","article-title":"Mesenchymal stem cell-mediated ectopic hematopoiesis alleviates aging-related phenotype in immunocompromised mice","volume":"113","author":"Yamaza","year":"2009","journal-title":"Blood"},{"key":"2024020320130219100_bib24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2024020320130219100_bib25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0140-6736(08)60666-2","article-title":"Mesenchymal stem cells as cellular immunosuppressants","volume":"371","author":"Wolf","year":"2008","journal-title":"Lancet"},{"key":"2024020320130219100_bib26","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"key":"2024020320130219100_bib27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1634\/stemcells.2007-0737","article-title":"The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury","volume":"26","author":"Oh","year":"2008","journal-title":"Stem Cells"},{"key":"2024020320130219100_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1517\/14712598.8.5.569","article-title":"Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies","volume":"8","author":"Iyer","year":"2008","journal-title":"Exp Opin Biol Ther"},{"key":"2024020320130219100_bib29","first-page":"1165","article-title":"The effect of zoledronic acid on the function and differentiation of myeloid cells","volume":"91","author":"Wolf","year":"2006","journal-title":"Haematologica"},{"key":"2024020320130219100_bib30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2006-09-044321","article-title":"Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid","volume":"110","author":"Fiore","year":"2007","journal-title":"Blood"},{"key":"2024020320130219100_bib31","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1158\/0008-5472.CAN-07-1882","article-title":"Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma","volume":"67","author":"Melani","year":"2007","journal-title":"Cancer Res"},{"key":"2024020320130219100_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","article-title":"Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncol"},{"key":"2024020320130219100_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp 3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat Immunol"},{"key":"2024020320130219100_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"2024020320130219100_bib35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10875-008-9239-7","article-title":"Interplay between effector Th17 and regulatory T cells","volume":"28","author":"Awasthi","year":"2008","journal-title":"J Clin Immunol"},{"key":"2024020320130219100_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","article-title":"The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models","volume":"7","author":"Lubberts","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2024020320130219100_bib37","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin-17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrinton","year":"2005","journal-title":"Nat Immunol."},{"key":"2024020320130219100_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"2024020320130219100_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri1807","article-title":"Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells","volume":"6","author":"Dong","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2024020320130219100_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-051X.2005.00684.x","article-title":"Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from persons with chronic periodontitis","volume":"2","author":"Vernal","year":"2005","journal-title":"J Clin Periodontol"},{"key":"2024020320130219100_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-051X.2005.00676.x","article-title":"The potential role of interleukin-17 in the immunopathology of periodontal disease","volume":"32","author":"Takahashi","year":"2005","journal-title":"J Clin Periodontol"},{"key":"2024020320130219100_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1902\/jop.2004.75.1.37","article-title":"Interleukin-11 and IL-17 and the pathogenesis of periodontal disease","volume":"75","author":"Johnson","year":"2004","journal-title":"J Periodontol"},{"key":"2024020320130219100_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates: histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"2024020320130219100_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.humpath.2005.09.018","article-title":"Actinomycosis in infected osteoradionecrosis: underestimated?","volume":"37","author":"Hansen","year":"2006","journal-title":"Hum Pathol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.37","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/25\/7\/1668\/56577937\/jbmr37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/25\/7\/1668\/56577937\/jbmr37.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:03:38Z","timestamp":1710327818000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/25\/7\/1668-1679\/7600188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,30]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,6,30]]},"published-print":{"date-parts":[[2010,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.37","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,7,1]]},"published":{"date-parts":[[2010,6,30]]}}}